|
1
|
Sanders MC, Goldstein AL and Wang YL:
Thymosin beta 4 (Fx peptide) is a potent regulator of actin
polymerization in living cells. Proc Natl Acad Sci USA.
89:4678–4682. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ito M, Iguchi K, Usui S and Hirano K:
Overexpression of thymosin beta4 increases pseudopodia formation in
LNCaP prostate cancer cells. Biol Pharm Bul. 32:1101–1104. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tang MC, Chan LC, Yeh YC, Chen CY, Chou
TY, Wang WS and Su Y: Thymosin beta 4 induces colon cancer cell
migration and clinical metastasis via enhancing ILK/IQGAP1/Rac1
signal transduction pathway. Cancer Lett. 308:162–171. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bock-Marquette I, Saxena A, White MD,
Dimaio JM and Srivastava D: Thymosin beta4 activates
integrin-linked kinase and promotes cardiac cell migration,
survival and cardiac repair. Nature. 432:466–472. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Malinda KM, Goldstein AL and Kleinman HK:
Thymosin beta 4 stimulates directional migration of human umbilical
vein endothelial cells. FASEB J. 11:474–481. 1997.PubMed/NCBI
|
|
6
|
Sosne G, Hafeez S, Greenberry AL II and
Kurpakus-Wheater M: Thymosin beta4 promotes human conjunctival
epithelial cell migration. Curr Eye Res. 24:268–273. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cierniewski CS, Sobierajska K, Selmi A,
Kryczka J and Bednarek R: Thymosin β4 is rapidly internalized by
cells and does not induce intracellular Ca2+ elevation. Ann N Y
Acad Sci. 1269:44–52. 2012.
|
|
8
|
Grant DS, Rose W, Yaen C, Goldstein A,
Martinez J and Kleinman H: Thymosin beta4 enhances endothelial cell
differentiation and angiogenesis. Angiogenesis. 3:125–135. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reti R, Kwon E, Qiu P, Wheater M and Sosne
G: Thymosin beta4 is cytoprotective in human gingival fibroblasts.
Eur J Oral Sci. 116:424–430. 2008. View Article : Google Scholar
|
|
10
|
Kumar S and Gupta S: Thymosin beta 4
prevents oxidative stress by targeting antioxidant and
anti-apoptotic genes in cardiac fibroblasts. Plos One.
6:e269122011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sosne G, Qiu P, Christopherson PL and
Wheater MK: Thymosin beta 4 suppression of corneal NFkappaB: A
potential anti-inflammatory pathway. Exp Eye Res. 84:663–669. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huff T, Otto AM, Müller CS, Meier M and
Hannappel E: Thymosin beta4 is released from human blood platelets
and attached by factor XIIIa (transglutaminase) to fibrin and
collagen. FASEB J. 16:691–696. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Philp D, Badamchian M, Scheremeta B,
Nguyen M, Goldstein AL and Kleinman HK: Thymosin beta 4 and a
synthetic peptide containing its actin-binding domain promote
dermal wound repair in db/db diabetic mice and in aged mice. Wound
Repair Regen. 11:19–24. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee HG and Eun HC: Differences between
fibroblasts cultured from oral mucosa and normal skin: implication
to wound healing. J Dermatol Sci. 21:176–182. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Häkkinen L, Uitto VJ and Larjava H: Cell
biology of gingival wound healing. Periodontology 2000. 24:127–152.
2000.
|
|
16
|
Lygoe KA, Norman JT, Marshall JF and Lewis
MP: alphaV integrins play an important role in myofibroblast
differentiation. Wound Repair Regen. 12:461–470. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kozlovsky A, Artzi Z, Hirshberg A,
Israeli-Tobias C and Reich L: Effect of local antimicrobial agents
on excisional palatal wound healing: a clinical and
histomorphometric study in rats. J Clin Periodontol. 34:164–171.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hammad HM, Hammad MM, Abdelhadi IN and
Khalifeh MS: Effects of topically applied agents on intra-oral
wound healing in a rat model: a clinical and histomorphometric
study. Int J Dent Hyg. 9:9–16. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shanmugam M, Kumar TS, Arun KV, Arun R and
Karthik SJ: Clinical and histological evaluation of two dressing
materials in the healing of palatal wounds. J Indian Soc
Periodontol. 14:241–244. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ayvazyan A, Morimoto N, Kanda N, Takemoto
S, Kawai K, Sakamoto Y, Taira T and Suzuki S: Collagen-gelatin
scaffold impregnated with bFGF accelerates palatal wound healing of
palatal mucosa in dogs. J Surg Res. 171:e247–e257. 2011. View Article : Google Scholar
|
|
21
|
Badamchian M, Damavandy AA, Damavandy H,
Wadhwa SD, Katz B and Goldstein AL: Identification and
quantification of thymosin beta4 in human saliva and tears. Ann N Y
Acad Sci. 1112:458–465. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kwon E, Jacobs LC and Wheater M: Gingival
crevicular fluid levels of thymosin beta4 in periodontal health and
disease. J Adv Oral Res. 4:1–6. 2013.
|
|
23
|
Singer AJ and Clark RA: Cutaneous wound
healing. N Engl J Med. 341:738–746. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Philp D, Scheremeta B, Sibliss K, Zhou M,
Fine EL, Nguyen M, Wahl L, Hoffman MP and Kleinman HK: Thymosin
beta4 promotes matrix metalloproteinase expression during wound
repair. J Cell Physiol. 208:195–200. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qiu P, Kurpakus-Wheater M and Sosne G:
Matrix metalloproteinase activity is necessary for thymosin beta 4
promotion of epithelial cell migration. J Cell Physiol.
212:165–173. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mäkelä M, Salo T, Uitto VJ and Larjava H:
Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity:
cellular origin and relationship to periodontal status. J Dent Res.
73:1397–1406. 1994.PubMed/NCBI
|
|
27
|
Salo T, Mäkelä M, Kylmäniemi M,
Autio-Harmainen H and Larjava H: Expression of matrix
metalloproteinase-2 and -9 during early human wound healing. Lab
Invest. 70:176–182. 1994.PubMed/NCBI
|
|
28
|
Moon EY, Im YS, Ryu YK and Kang JH:
Actin-sequestering protein, thymosin beta-4, is a novel hypoxia
responsive regulator. Clin Exp Metastasis. 27:601–609. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Oh JM, Ryoo IJ, Yang Y, Kim HS, Yang KH
and Moon EY: Hypoxia-inducible transcription factor (HIF)-1 alpha
stabilization by actin-sequestering protein, thymosin beta-4 (TB4)
in HeLa cervical tumor cells. Cancer Lett. 264:29–35. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ahn JK, Koh EM, Cha HS, Lee YS, Kim J, Bae
EK and Ahn KS: Role of hypoxia-inducible factor-1 alpha in
hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid
fibroblast-like synoviocytes. Rheumatology (Oxford). 47:834–839.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ben-Yosef Y, Miller A, Shapiro S and Lahat
N: Hypoxia of endothelial cells leads to MMP-2-dependent survival
and death. Am J Physiol Cell Physiol. 289:C1321–C1331. 2005.
View Article : Google Scholar : PubMed/NCBI
|
